Drug:
Reaction: INCORRECT DOSE ADMINISTERED
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25120736 |
US |
||
Visual impairment, Paraesthesia, Incorrect dose administered, Inappropriate schedule of product administration, |
||||
EXENATIDE, |
||||
| 502 | 25120767 |
US |
||
Incorrect dose administered, Incorrect dose administered, Cough, Incorrect dose administered, Visual impairment, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 503 | 25120781 |
US |
67 | 2 |
Incorrect dose administered, |
||||
DULAGLUTIDE, |
||||
| 504 | 25120907 |
US |
24 | 1 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 505 | 25109807 |
FI |
||
Large intestinal obstruction, Incorrect dose administered, Product complaint, Product residue present, Constipation, Diarrhoea, Neuralgia, Pain, |
||||
EXENATIDE, |
||||
| 506 | 25110026 |
US |
38 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 507 | 25110027 |
US |
40 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 508 | 25110168 |
US |
62 | 1 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 509 | 25110385 |
GB |
61 | 2 |
Blindness, Burning sensation, Pain in extremity, Drug hypersensitivity, Injection site pain, Product availability issue, Incorrect dose administered, Off label use, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 510 | 25110432 |
US |
57 | 2 |
Incorrect dose administered, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 511 | 25110436 |
US |
||
Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 512 | 25110437 |
US |
||
Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 513 | 25110483 |
US |
35 | 2 |
Incorrect dose administered, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 514 | 25110506 |
US |
76 | 2 |
Accidental exposure to product, Off label use, No adverse event, Incorrect dose administered, Device defective, Wrong technique in product usage process, |
||||
TOCILIZUMAB, |
||||
| 515 | 25110551 |
US |
68 | |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 516 | 25110570 |
US |
2 | |
Wrong technique in device usage process, Incorrect dose administered, |
||||
ALBUTEROL SULFATE, |
||||
| 517 | 25110662 |
US |
||
Fatigue, Loss of libido, Incorrect dose administered, |
||||
RELUGOLIX, DEGARELIX, |
||||
| 518 | 25110663 |
US |
||
Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 519 | 25110721 |
US |
32 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 520 | 25110820 |
GB |
2 | |
Motor neurone disease, Disease progression, Incorrect dose administered, |
||||
SOMATROPIN, |
||||
| 521 | 25110994 |
GR |
6 | 2 |
Injection site pain, Incorrect dose administered, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 522 | 25111047 |
US |
36 | 1 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 523 | 25111108 |
AU |
70 | 1 |
Hyperthyroidism, Hypotension, Renal impairment, Incorrect dose administered, Labelled drug-drug interaction issue, Product physical issue, |
||||
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CARVEDILOL, CARVEDILOL, EZETIMIBE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PROPYLTHIOURACIL, ROSUVASTATIN CALCIUM, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, |
||||
| 524 | 25111250 |
US |
59 | |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 525 | 25111252 |
US |
60 | 2 |
Incorrect dose administered, Injection site injury, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 526 | 25111311 |
US |
||
Night sweats, Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 527 | 25111378 |
US |
45 | 2 |
Product storage error, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 528 | 25111478 |
US |
49 | 1 |
Spinal stenosis, Pain, Nightmare, Pancreatitis chronic, Incorrect dose administered, Hospitalisation, |
||||
PANCRELIPASE, OXYCODONE, |
||||
| 529 | 25111583 |
US |
||
Blood calcium decreased, Incorrect dose administered, |
||||
RELUGOLIX, ENZALUTAMIDE, |
||||
| 530 | 25111585 |
US |
||
Prostate cancer metastatic, Metastases to bone, Shoulder operation, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 531 | 25111742 |
US |
63 | 1 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 532 | 25111743 |
US |
41 | 2 |
Incorrect dose administered, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 533 | 25111782 |
US |
||
Fatigue, Asthenia, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 534 | 25111934 |
US |
96 | |
Incorrect dose administered, Inappropriate schedule of product administration, Product label issue, |
||||
ACETAMINOPHEN, |
||||
| 535 | 25112097 |
US |
64 | 2 |
Incorrect dose administered, Injection site erythema, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 536 | 25112099 |
US |
59 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 537 | 25112101 |
US |
52 | 1 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 538 | 25112102 |
US |
||
Incorrect dose administered, |
||||
TIRZEPATIDE, |
||||
| 539 | 25112268 |
US |
2 | |
Poor quality sleep, Dizziness, Tremor, Incorrect dose administered, Product dose omission issue, Product distribution issue, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 540 | 25112386 |
US |
2 | |
Incorrect dose administered, Product use complaint, |
||||
BRIVARACETAM, |
||||
| 541 | 25112426 |
US |
38 | 1 |
Seizure, Aggression, Somnolence, Fatigue, Hunger, Feeling abnormal, Constipation, Head injury, Wrong technique in product usage process, Incorrect dose administered, Product use issue, |
||||
BRIVARACETAM, BRIVARACETAM, TAURINE, |
||||
| 542 | 25112475 |
US |
2 | |
Alopecia, Nasopharyngitis, Sinusitis, Drug ineffective, Incorrect dose administered, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 543 | 25112500 |
US |
82 | 2 |
Incorrect dose administered, Off label use, Urticaria, Injection site vesicles, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 544 | 25112549 |
US |
2 | |
Incorrect dose administered, Device malfunction, |
||||
BIMEKIZUMAB, |
||||
| 545 | 25112572 |
US |
2 | |
Incorrect dose administered, Device issue, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 546 | 25112592 |
US |
1 | |
Drug ineffective, Product dose omission issue, Incorrect dose administered, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 547 | 25112594 |
US |
72 | 2 |
Injection site pain, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 548 | 25112603 |
US |
2 | |
Incorrect dose administered, Device issue, |
||||
BIMEKIZUMAB, |
||||
| 549 | 25112628 |
US |
2 | |
Incorrect dose administered, Device issue, |
||||
BIMEKIZUMAB, |
||||
| 550 | 25112658 |
CA |
29 | 2 |
Urticaria, Weight decreased, Injection site pain, Incorrect dose administered, Needle issue, Erythema, Skin irritation, Pruritus, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, LORATADINE, LORATADINE TABLET, CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 551 | 25112766 |
US |
2 | |
Device leakage, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 552 | 25112768 |
US |
2 | |
Injection site bruising, Injection site pain, Device issue, Incorrect dose administered, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 553 | 25112902 |
US |
2 | |
Alopecia, Incorrect dose administered, |
||||
MINOXIDIL, |
||||
| 554 | 25112923 |
US |
1 | |
Incorrect dose administered, Wrong technique in product usage process, |
||||
BIMEKIZUMAB, |
||||
| 555 | 25112946 |
US |
1 | |
Injection site pain, Incorrect dose administered, Wrong technique in product usage process, |
||||
BIMEKIZUMAB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FLUOXETINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NABUMETONE, DICYCLOMINE HYDROCHLORIDE, WARFARIN SODIUM, WARFARIN, GABAPENTIN, METHOTREXATE, METHOTREXATE SODIUM, FUROSEMIDE, TAMSULOSIN HYDROCHLORIDE, TIRZEPATIDE, GLIPIZIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, PREDNISONE, IRON, ERGOCALCIFEROL, LISINOPRIL, |
||||
| 556 | 25112958 |
US |
2 | |
Device issue, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 557 | 25112959 |
US |
2 | |
Product dispensing issue, Device issue, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 558 | 25113013 |
US |
2 | |
Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 559 | 25113019 |
US |
1 | |
Incorrect dose administered, Product dispensing error, |
||||
BIMEKIZUMAB, |
||||
| 560 | 25113043 |
US |
71 | 1 |
Pneumonia, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 561 | 25113095 |
US |
38 | 2 |
Burning sensation, Injection site urticaria, Malaise, Skin reaction, Hypoaesthesia, Accidental exposure to product, Incorrect dose administered, Wrong technique in product usage process, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 562 | 25113197 |
US |
23 | 1 |
Injection site pain, Incorrect dose administered, Drug ineffective, |
||||
BIMEKIZUMAB, ATOMOXETINE HYDROCHLORIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 563 | 25113239 |
US |
1 | |
Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 564 | 25113281 |
US |
64 | 1 |
Product dose omission issue, Accidental exposure to product, Device malfunction, Incorrect dose administered, Device use error, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 565 | 25113286 |
US |
2 | |
Incorrect dose administered, Device issue, |
||||
BIMEKIZUMAB, |
||||
| 566 | 25113290 |
US |
2 | |
Product availability issue, Device issue, Product leakage, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 567 | 25113311 |
US |
26 | 2 |
Dry skin, Rash, Tonsillar disorder, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 568 | 25113314 |
US |
1 | |
Device issue, Incorrect dose administered, |
||||
BIMEKIZUMAB, |
||||
| 569 | 25113315 |
US |
1 | |
Incorrect dose administered, Product supply issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 570 | 25113316 |
US |
52 | 1 |
Arthralgia, Intentional dose omission, Accidental exposure to product, Device malfunction, Incorrect dose administered, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 571 | 25113319 |
US |
56 | 1 |
Device issue, Incorrect dose administered, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 572 | 25113328 |
US |
2 | |
Incorrect dose administered, Device issue, Product dose omission issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, SEMAGLUTIDE, INSULIN GLARGINE, CYCLOSPORINE, LISINOPRIL, EMPAGLIFLOZIN, ERGOCALCIFEROL, FISH OIL, HYDROCHLOROTHIAZIDE, GABAPENTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SIMVASTATIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 573 | 25113680 |
US |
2 | |
Nausea, Influenza, Poor quality product administered, Incorrect dose administered, Product odour abnormal, Product colour issue, Product size issue, Product taste abnormal, Product physical issue, |
||||
ICOSAPENT ETHYL, ICOSAPENT ETHYL, ICOSAPENT ETHYL, |
||||
| 574 | 25113696 |
US |
33 | 2 |
Incorrect dose administered, Off label use, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 575 | 25113701 |
US |
47 | |
Incorrect dose administered, Injection site pain, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 576 | 25113704 |
US |
59 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 577 | 25113708 |
US |
40 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 578 | 25113728 |
US |
68 | 1 |
Retching, Vomiting, Blood triglycerides increased, Incorrect dose administered, Poor quality product administered, Product after taste, Product odour abnormal, Product physical issue, Product taste abnormal, |
||||
ICOSAPENT ETHYL, ICOSAPENT ETHYL, ICOSAPENT ETHYL, |
||||
| 579 | 25113806 |
US |
77 | 1 |
Urine odour abnormal, Pruritus, Burns second degree, Thermal burn, Poor quality product administered, Incorrect dose administered, Product odour abnormal, Product physical issue, |
||||
ICOSAPENT ETHYL, |
||||
| 580 | 25114037 |
US |
75 | 2 |
Urticaria, Dyspnoea, Pruritus, Throat tightness, Drug hypersensitivity, Incorrect dose administered, Product lot number issue, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
| 581 | 25114286 |
US |
85 | 1 |
Cough, Dyspnoea, Incorrect dose administered, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 582 | 25114289 |
US |
1 | |
Injection site pain, Product preparation error, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 583 | 25114295 |
US |
35 | 2 |
Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 584 | 25114579 |
US |
52 | 2 |
Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 585 | 25114582 |
US |
20 | 2 |
Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 586 | 25114623 |
US |
2 | |
Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 587 | 25114953 |
FR |
82 | 1 |
Acute myeloid leukaemia, Pancytopenia, Incorrect dose administered, Overdose, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 588 | 25115096 |
US |
55 | 1 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 589 | 25115169 |
US |
63 | 1 |
Incorrect dose administered, |
||||
ADALIMUMAB, |
||||
| 590 | 25115326 |
US |
||
Headache, Incorrect dose administered, |
||||
RELUGOLIX, ENZALUTAMIDE, |
||||
| 591 | 25115395 |
US |
35 | 2 |
Drug dependence, Therapeutic response unexpected, Incorrect product administration duration, Incorrect dose administered, |
||||
ALKA-SELTZER GOLD, |
||||
| 592 | 25115470 |
US |
11 | 1 |
Incorrect drug administration rate, Device delivery system issue, Incorrect dose administered, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 593 | 25109204 |
US |
74 | 1 |
Blood glucose increased, Incorrect dose administered, Device delivery system issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 594 | 25109209 |
US |
72 | 2 |
Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 595 | 25109215 |
US |
78 | 1 |
Drug ineffective, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 596 | 25109238 |
US |
45 | 2 |
Incorrect dose administered, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 597 | 25109290 |
US |
66 | 2 |
Food craving, Hunger, Weight increased, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, PIOGLITAZONE, CLOPIDOGREL, RIVAROXABAN, |
||||
| 598 | 25109354 |
US |
30 | 2 |
Product dose omission issue, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 599 | 25109357 |
US |
33 | 2 |
Dermatitis atopic, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 600 | 25109366 |
US |
43 | 2 |
Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28